Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Strive, Inc. filings document the company’s structured finance and asset management business, bitcoin treasury operations, preferred stock structure, and public-company governance. Its 8-K reports disclose business updates such as bitcoin, cash, investment and capital stock balances, dividend actions for the Variable Rate Series A Perpetual Preferred Stock, and quarterly operating and financial results.
Strive’s SEC record also includes proxy materials for annual meeting matters, including auditor ratification, and disclosures identifying the company as a Nevada corporation and emerging growth company. Filing subjects include Class A and Class B common stock, SATA preferred stock, advisory activities through Strive Asset Management, LLC, forward-looking risk language, and material-event reporting tied to capital allocation and treasury strategy.
Semler Scientific (SMLR) and Strive, Inc. filed a Form 425 communication tied to their proposed business combination. The notice, reposted on X by Strive’s Chief Legal Officer, contains forward-looking statements and cautions about related risks. Strive intends to file a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive definitive materials to vote on the deal. Documents will be available on the SEC website and the companies’ investor sites. This is not an offer to sell securities.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). Strive plans to file a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement/proxy statement/prospectus.
Semler Scientific stockholders will receive definitive materials to vote on the proposed transaction. The notice includes cautionary forward-looking statements and clarifies it is not an offer or solicitation to sell securities.
Strive, Inc. reposted a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive plans to file a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus for Semler stockholders.
A definitive proxy will be sent to Semler stockholders to seek approval. Related documents will be available free on the SEC’s website and the companies’ investor sites. The notice emphasizes forward-looking statement risks and clarifies this is not an offer to sell or solicit any security.
Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). Strive intends to file a Form S-4 to register Class A common stock to be issued in connection with the transaction, and a combined information statement/proxy statement/prospectus will be sent to Semler stockholders to seek their approval.
The notice includes standard forward‑looking statements, identifies potential solicitation participants, and states this is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc.
Strive intends to file a Form S-4 to register Class A common stock to be issued in the transaction, with an Information Statement/Proxy Statement/Prospectus to be sent to Semler Scientific stockholders to seek their approval. The communication includes forward-looking statement cautions and directs investors to the SEC’s website and the companies’ investor pages for the Registration Statement and related materials when available.
Strive, Inc. filed a Form 425 communication about its proposed business combination with Semler Scientific, Inc. The notice states Strive intends to file a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement/proxy statement/prospectus.
A definitive proxy will be sent to Semler Scientific stockholders to seek their approval. The communication includes cautionary forward-looking statements and a standard “no offer or solicitation” disclaimer, directing investors to future SEC filings for full details.
Strive, Inc. posted a communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The notice includes a forward‑looking statements disclaimer and outlines next steps for the transaction process.
Strive intends to file a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive proxy materials to vote on the proposed transaction. This communication is not an offer to sell or solicit the purchase of securities.
Strive, Inc. announced a proposed business combination with Semler Scientific and outlined next steps in the regulatory process. Strive intends to file an S-4 registration statement to register Class A common stock to be issued in the transaction, which will include an information statement, proxy statement for Semler Scientific stockholders, and a prospectus.
A definitive proxy/prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction. The communication includes a standard caution about forward-looking statements and directs investors to review the S-4 and related materials when available on the SEC’s website and the companies’ investor sites.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc.
Strive plans to file a Form S-4 to register Class A common stock to be issued in the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes a comprehensive forward‑looking statements caution.
Transaction materials will be available on the SEC’s website and the companies’ investor relations sites. The notice states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. shared a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The message, reposted on X by Strive’s CMO on October 24, 2025, includes a standard caution that forward‑looking statements involve risks and uncertainties. Strive plans to file a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus. Semler stockholders will receive materials to consider the proposal, and related documents will be available on the SEC’s website and the companies’ investor pages.